Cargando…

The sequence of structural, functional and cognitive changes in multiple sclerosis

BACKGROUND: As disease progression remains poorly understood in multiple sclerosis (MS), we aim to investigate the sequence in which different disease milestones occur using a novel data-driven approach. METHODS: We analysed a cohort of 295 relapse-onset MS patients and 96 healthy controls, and cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekker, Iris, Schoonheim, Menno M., Venkatraghavan, Vikram, Eijlers, Anand J.C., Brouwer, Iman, Bron, Esther E., Klein, Stefan, Wattjes, Mike P., Wink, Alle Meije, Geurts, Jeroen J.G., Uitdehaag, Bernard M.J., Oxtoby, Neil P., Alexander, Daniel C., Vrenken, Hugo, Killestein, Joep, Barkhof, Frederik, Wottschel, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804841/ https://www.ncbi.nlm.nih.gov/pubmed/33418173 http://dx.doi.org/10.1016/j.nicl.2020.102550

Ejemplares similares

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis
por: Huiskamp, Marijn, et al.
Publicado: (2021)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Predicting clinical progression in multiple sclerosis after 6 and 12 years
por: Dekker, I., et al.
Publicado: (2019)

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2017)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2022)

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
por: Dekker, Iris, et al.
Publicado: (2019)

Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2020)

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS
por: Schoonhoven, Deborah N, et al.
Publicado: (2018)

A more unstable resting-state functional network in cognitively declining multiple sclerosis
por: Broeders, Tommy A. A., et al.
Publicado: (2022)

The cerebellum and its network: Disrupted static and dynamic functional connectivity patterns and cognitive impairment in multiple sclerosis
por: Schoonheim, Menno M, et al.
Publicado: (2021)

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017)

Eigenvector Centrality Dynamics From Resting-State fMRI: Gender and Age Differences in Healthy Subjects
por: Wink, Alle Meije
Publicado: (2019)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease()
por: Archetti, Damiano, et al.
Publicado: (2019)

Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis
por: Nauta, Ilse M, et al.
Publicado: (2020)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

BOLD Noise Assumptions in fMRI
por: Wink, Alle Meije, et al.
Publicado: (2006)

Data-driven haemodynamic response function extraction using Fourier-wavelet regularised deconvolution
por: Wink, Alle Meije, et al.
Publicado: (2008)

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects
por: Weeda, M.M., et al.
Publicado: (2019)

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022)

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
por: Kilsdonk, Iris D, et al.
Publicado: (2017)

The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics
por: Schoonheim, Menno M., et al.
Publicado: (2022)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis
por: Tijhuis, Floris B., et al.
Publicado: (2021)

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
por: Broos, Jelle Y., et al.
Publicado: (2023)

Multiple sclerosis and drug discovery: A work of translation
por: ’t Hart, Bert A., et al.
Publicado: (2021)

Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
por: Wijburg, Martijn T., et al.
Publicado: (2016)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Disease activity following pregnancy-related discontinuation of natalizumab in MS
por: Kleerekooper, Iris, et al.
Publicado: (2017)

Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship
por: van Loenhoud, Anna Catharina, et al.
Publicado: (2019)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
por: Collij, Lyduine E., et al.
Publicado: (2021)

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective
por: Rocca, Maria A., et al.
Publicado: (2022)

Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis
por: Collij, Lyduine E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgpekvs96ns0p7a2mdnbgo6kee